nytimes.com /1 month ago

Scientists Untangle the Biology of an ‘Undruggable’ Cancer Gene

Found in 70 percent of cancers, the gene is seen as a grand orchestrator but has been surprisingly difficult to stop.

Read source
bioengineer.org /1 month ago

Nerves and Tumours Talk: How the Nervous System Drives Cancer Growth and Drug Resistance

Cancer has long been framed as a disease of rogue genes, a story written almost entirely in the language of mutations, checkpoints and clonal evolution. A new review published in M...

Read source
bioengineer.org /1 week ago

Researchers Review SQSTM1 and p62 Dual Roles Across Cancer Development

A comprehensive review outlines how the selective autophagy receptor SQSTM1/p62 coordinates stress responses, oncogenic signaling, and metabolic adaptation across diverse malignanc...

Read source
scitechdaily.com /1 month ago

Biologists Discover a Cellular Pathway That Helps Colorectal Cancer Spread

Obesity may boost activity in a tissue repair pathway that helps colon cancer spread, offering a potential target for drugs to prevent metastasis. Most colon cancer deaths occur wh...

Read source
asianscientist.com /1 month ago

This Molecular Switch Helps Triple-Negative Breast Cancers Resist Treatment

Researchers uncover how the long non-coding RNA Smyca helps triple-negative breast cancer cells repair DNA damage and survive treatment.

Read source
bioengineer.org /1 month ago

Metarrestin’s Anti-Cancer Mechanism Mapped Through Network Pharmacology

A new network pharmacology study maps how the anti-metastatic drug metarrestin rewires cancer cell protein networks and identifies the cell-cycle regulator CDKN1B as its highest-af...

Read source
bioengineer.org /6 days ago

Non-coding RNA networks in tumor fibroblasts drive cancer progression, review finds

A review describes how non-coding RNA networks in cancer-associated fibroblasts regulate tumor progression, exosomal communication, and therapeutic resistance.

Read source
bioengineer.org /1 week ago

KLHL6 protein drives colorectal cancer liver spread via MBD2 degradation

A study in the Journal of Experimental & Clinical Cancer Research identifies KLHL6 as a driver of colorectal cancer liver metastasis through the degradation of MBD2 and activat...

Read source
aacr.org /2 weeks ago

Cracking “Undruggable” Cancer Proteins: Precision Oncology Meets p53

The development of KRAS inhibitors has ushered in a new era in precision oncology and renewed efforts in therapeutic targeting of p53, the most commonly altered gene in human cance...

Read source
aacr.org /3 weeks ago

From the Bench, Fall 2026: Virtual Cells, Talking Cells, Eating Cells, and More

In the latest edition of From the Bench, the AACR Blog explores recent innovative approaches to cancer research, including a method for limiting maternal-fetal transmission of cert...

Read source
bioengineer.org /6 days ago

Interpretable Graph Learning Framework CGMap Prioritizes Cancer Genes Across Biomolecular Networks

Researchers developed CGMap, an interpretable graph-learning framework that prioritized 70 reliable cancer gene candidates across multiple biomolecular networks in a pan-cancer ana...

Read source
bioengineer.org /4 weeks ago

Review Connects Circadian Clock Disruption With Cancer Metabolism and Progression

A 2026 review links disrupted circadian clock genes with altered cancer metabolism, cell survival, and pathways implicated in tumor progression.

Read source
fightaging.org /1 month ago

Known Cancer-Associated Genetic Sequences are More Conserved in Long-Lived Species

Suppression of cancer is a necessary component of species longevity, and finding out how exactly cancer incidence is in some cases dramatically reduced is one of the primary goals...

Read source
bioengineer.org /1 month ago

Lab-Grown Tumor Chips and AI Join Forces to Outsmart Glioblastoma

Glioblastoma, the most aggressive cancer that begins in the brain, has stubbornly resisted decades of progress in oncology. Even with the current standard of care, which combines m...

Read source
bioengineer.org /2 weeks ago

Stiff Tumors Talk to Immune Cells: How Mechanical Forces Shape Cancer and Immunity

A new Frontiers editorial argues that mechanical forces in tumors regulate invasion, immune surveillance, and treatment response, and that the field is shifting from cataloguing me...

Read source
bioengineer.org /1 week ago

Demethylzeylasteral Suppresses Mammary Tumor Growth by Modulating MDM2-p21 Signaling

Researchers demonstrated that the triterpenoid demethylzeylasteral induces G1 phase arrest and mitochondrial apoptosis in breast cancer models through modulation of the MDM2-p21 mo...

Read source
bioengineer.org /1 month ago

Cancer’s Hidden Helpers: Fibroblast Diversity Reshapes How Tumors Spread and How We Treat Them

Cancer rarely travels alone. When tumor cells leave their original home and seed new colonies in distant organs, they are escorted, sheltered, and often actively coached by an ento...

Read source
fightaging.org /3 weeks ago

Cancer Can Emerge from Epigenetic Change Rather than DNA Mutation

Researchers here provide a demonstration that a form of liver cancer can emerge from change in the epigenetic control over gene expression in the absence of mutation of nuclear DNA...

Read source
bioengineer.org /1 month ago

How a Cellular Stress Switch Helps Tumours Hide From the Immune System

A new review reveals how the unfolded protein response, a cellular stress-signalling network, helps tumours evade immune detection and could be targeted to boost cancer immunothera...

Read source
labiotech.eu /4 days ago

Oncology biotech news: Key moves to watch in November 2026 

Delve into Labiotech's November oncology roundup and find out about the news that caught our attention this last month. The post Oncology biotech news: Key moves to watch in Novemb...

Read source
bioengineer.org /1 month ago

Circular RNA Revealed as Hidden Brake on Colorectal Cancer Growth

Researchers report that the circular RNA circMTCL1, sharply depleted in colorectal cancer tumors, suppresses cancer cell growth by sponging miR-145-5p, boosting BMP3, and damping M...

Read source
genengnews.com /1 month ago

How Cells Respond Differently to a Cancer-Causing Gene

Chemotherapies frequently cause cancer cells to enter senescence, but do not fully eliminate these cells. Therefore, it is useful to target these therapy-induced senescent cells wi...

Read source
aacr.org /1 month ago

Frontiers in Cancer Science 2026: What Can Cancer’s Past Tell Us About Its Future?

The 18th Frontiers in Cancer Science conference, to be held November 11-13 in Singapore, will explore what cancer's past can tell us about its future. The conference cochairs Gopal...

Read source
bioengineer.org /1 month ago

Old Drugs, New Tricks: How Repurposing Could Crack Cancer’s Resistance Problem

A new review in Molecular Cancer maps how approved drugs from outside oncology could be repurposed, under a strict mechanism-first framework, to dismantle the four biological progr...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.